Feverfew

Feverfew

What the trials found

Feverfew has not enough research to establish fewer migraine attacks in adults; one 24-week trial found no clear reduction, leaving prevention unproven.

Median effective dose, most-studied outcomes

Full protocol, 1 outcomes

Risk, worst reported severity

  • seizure severe
  • gastrointestinal complaints mild
All 8 events and interactions

What feverfew actually does

Outcome Effect Evidence Dose Time Rank
Early research 1
Fewer migraine attacks Not enough research Migraine prevention can mean fewer days shaped by head pain and missed plans.
1 RCT 1 papers · n=— 50 mg 24 wk

Effect tiers come from native-unit MCID where available, Cohen's d otherwise.

Protocol

Dose, timing & forms

How much

The only reviewed headache trial used 50 mg daily for 24 weeks. It did not show a statistically clear reduction in headache days, so the evidence does not establish a reliable dose for headache prevention.1

When and how long

The studied protocol used feverfew every day over months, not as an occasional remedy during a headache.1 The trial does not establish a best time of day or whether taking it with food changes results, so follow the product directions and keep any trial of it consistent.

Forms & standardisation

The clinical literature does not establish one best feverfew form. Products differ in plant material and parthenolide content, so do not assume a tea, whole-leaf capsule, and standardized extract deliver the same thing.2 If you choose a product, a label that identifies the plant part and discloses parthenolide content gives you more useful information than a vague feverfew claim.

Studied range, by outcome

Outcome Studied range Median effective Duration Evidence
Reduce headache days 50 mg 24 wk 1 paper

Adverse events and drug interactions

Safety events

seizure severe
gastrointestinal complaints mild
mouth ulcers mild
lethargy mild
Nervousness / tension / feeling jumpy
Insomnia / disturbed sleep / nocturnal restlessness
Stiffness or pain in joints
Palpitations
In context

What this is and how it works

  • One 24-week trial found no clear reduction in migraine attacks with feverfew.1
  • One paper reviewed here spans five feverfew outcomes, with evidence limited to early research.
  • Clinical evidence remains inconclusive across feverfew migraine-prevention research.2

Feverfew is a daisy-family herb, traditionally used in Europe for headaches and other complaints. Supplements usually contain dried feverfew leaf or a leaf extract, rather than the flower you might picture in a garden.2

Feverfew contains parthenolide, a plant compound that seems to turn down inflammatory chemical signals and activity in blood cells involved in clotting, like lowering the volume on an overactive alarm system.2 That biology gives researchers a reason to study feverfew for headaches, but it does not substitute for clinical results. The available 24-week trial did not establish fewer headache days.1

Bottom line

Feverfew is not a strong first choice if you want a supplement with convincing evidence for fewer headache days. One longer trial tested it without a clear benefit, and the broader review found inconclusive results.12 Reported concerns include mouth ulcers, digestive complaints, nervousness, and seizure risk, so anyone with a seizure history should speak with a clinician before using it.

Frequently asked

Common questions

Does feverfew prevent migraine or headache attacks?

It does not yet have convincing evidence for preventing attacks. The reviewed 24-week trial did not find a clear reduction in headache days, and a systematic review found the overall evidence inconclusive.12

What dose of feverfew was studied for headache days?

The reviewed trial used 50 mg daily for 24 weeks. Because that trial did not show a statistically clear benefit, this is a studied protocol, not a proven target dose.1

How long does feverfew take to work?

The trial followed participants for 24 weeks, but it did not establish a reliable benefit or a predictable time frame for improvement.1

Sources

Sources

  1. 1. The effect of feverfew on the prevention of migraine: A double-blind placebo-controlled study (1996)
  2. 2. Feverfew for preventing migraine (1999)

Generated August 27, 2026